Frailty assessment for COVID-19 follow-up: a prospective cohort study.
COVID-19
respiratory infection
Journal
BMJ open respiratory research
ISSN: 2052-4439
Titre abrégé: BMJ Open Respir Res
Pays: England
ID NLM: 101638061
Informations de publication
Date de publication:
04 2022
04 2022
Historique:
received:
10
02
2022
accepted:
08
04
2022
entrez:
23
4
2022
pubmed:
24
4
2022
medline:
27
4
2022
Statut:
ppublish
Résumé
The Clinical Frailty Scale (CFS) is increasingly used for clinical decision making in acute care but little is known about frailty after COVID-19. To investigate frailty and the CFS for post-COVID-19 follow-up. This prospective multicentre cohort study included COVID-19 survivors aged ≥50 years presenting for a follow-up visit ≥3 months after the acute illness. Nine centres retrospectively collected pre-COVID-19 CFS and prospectively CFS at follow-up. Three centres completed the Frailty Index (FI), the short physical performance battery (SPPB), 30 s sit-to-stand test and handgrip strength measurements. Mixed effect logistic regression models accounting for repeated measurements and potential confounders were used to investigate factors associated with post-COVID-19 CFS. Criterion and construct validity were determined by correlating the CFS to other concurrently assessed frailty measurements and measures of respiratory impairment, respectively. Of the 288 participants 65% were men, mean (SD) age was 65.1 (9) years. Median (IQR) CFS at follow-up was 3 (2-3), 21% were vulnerable or frail (CFS ≥4). The CFS was responsive to change, correlated with the FI (r=0.69, p<0.001), the SPPB score (r=-0.48, p<0.001) (criterion validity) and with the St George's Respiratory Questionnaire score (r=0.59, p<0.001), forced vital capacity %-predicted (r=-0.25, p<0.001), 6 min walk distance (r=-0.39, p<0.001) and modified Medical Research Council (mMRC) (r=0.59, p<0.001). Dyspnoea was significantly associated with a higher odds for vulnerability/frailty (per one mMRC adjusted OR 2.01 (95% CI 1.13 to 3.58), p=0.02). The CFS significantly increases with COVID-19, and dyspnoea is an important risk factor for post-COVID-19 frailty and should be addressed thoroughly.
Sections du résumé
BACKGROUND
The Clinical Frailty Scale (CFS) is increasingly used for clinical decision making in acute care but little is known about frailty after COVID-19.
OBJECTIVES
To investigate frailty and the CFS for post-COVID-19 follow-up.
METHODS
This prospective multicentre cohort study included COVID-19 survivors aged ≥50 years presenting for a follow-up visit ≥3 months after the acute illness. Nine centres retrospectively collected pre-COVID-19 CFS and prospectively CFS at follow-up. Three centres completed the Frailty Index (FI), the short physical performance battery (SPPB), 30 s sit-to-stand test and handgrip strength measurements. Mixed effect logistic regression models accounting for repeated measurements and potential confounders were used to investigate factors associated with post-COVID-19 CFS. Criterion and construct validity were determined by correlating the CFS to other concurrently assessed frailty measurements and measures of respiratory impairment, respectively.
RESULTS
Of the 288 participants 65% were men, mean (SD) age was 65.1 (9) years. Median (IQR) CFS at follow-up was 3 (2-3), 21% were vulnerable or frail (CFS ≥4). The CFS was responsive to change, correlated with the FI (r=0.69, p<0.001), the SPPB score (r=-0.48, p<0.001) (criterion validity) and with the St George's Respiratory Questionnaire score (r=0.59, p<0.001), forced vital capacity %-predicted (r=-0.25, p<0.001), 6 min walk distance (r=-0.39, p<0.001) and modified Medical Research Council (mMRC) (r=0.59, p<0.001). Dyspnoea was significantly associated with a higher odds for vulnerability/frailty (per one mMRC adjusted OR 2.01 (95% CI 1.13 to 3.58), p=0.02).
CONCLUSIONS
The CFS significantly increases with COVID-19, and dyspnoea is an important risk factor for post-COVID-19 frailty and should be addressed thoroughly.
Identifiants
pubmed: 35459694
pii: 9/1/e001227
doi: 10.1136/bmjresp-2022-001227
pmc: PMC9035838
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Eur Respir J. 2005 Sep;26(3):511-22
pubmed: 16135736
CMAJ. 2005 Aug 30;173(5):489-95
pubmed: 16129869
BMC Geriatr. 2002 Feb 27;2:1
pubmed: 11897015
Lancet Healthy Longev. 2021 Mar;2(3):e163-e170
pubmed: 33655235
Lancet Public Health. 2020 Aug;5(8):e444-e451
pubmed: 32619408
J Am Med Dir Assoc. 2019 Oct;20(10):1190-1198
pubmed: 31564464
Chronic Obstr Pulm Dis. 2022 Jan 27;9(1):15-25
pubmed: 34755502
Geriatrics (Basel). 2020 Sep 21;5(3):
pubmed: 32967236
J Gerontol A Biol Sci Med Sci. 2020 Jan 20;75(2):387-393
pubmed: 30789645
Am J Respir Crit Care Med. 2019 Oct 15;200(8):e70-e88
pubmed: 31613151
Eur Respir J. 2014 Dec;44(6):1428-46
pubmed: 25359355
Thorax. 2020 Aug;75(8):669-678
pubmed: 32376733
Ageing Res Rev. 2019 Mar;50:81-88
pubmed: 30659942
Respir Med. 2017 Aug;129:1-7
pubmed: 28732817
Arch Gerontol Geriatr. 2015 May-Jun;60(3):464-70
pubmed: 25697060
J Nutr Health Aging. 2020;24(9):948-950
pubmed: 33155619
Anaesth Crit Care Pain Med. 2020 Jun;39(3):333-339
pubmed: 32426441
Age Ageing. 2020 Oct 23;49(6):915-922
pubmed: 32778870
EClinicalMedicine. 2021 May 23;36:100896
pubmed: 34036252
BMC Geriatr. 2021 Apr 21;21(1):263
pubmed: 33882862
Can Geriatr J. 2020 Sep 01;23(3):210-215
pubmed: 32904824
J Gerontol. 1994 Mar;49(2):M85-94
pubmed: 8126356
ScientificWorldJournal. 2001 Aug 08;1:323-36
pubmed: 12806071
CMAJ. 2011 May 17;183(8):E487-94
pubmed: 21540166
Aging Clin Exp Res. 2011 Apr;23(2):118-25
pubmed: 21743290
Ann Intensive Care. 2021 Feb 3;11(1):22
pubmed: 33534010
Nature. 2020 Aug;584(7821):430-436
pubmed: 32640463
Am J Surg. 2015 Feb;209(2):254-9
pubmed: 25173599
Eur Respir J. 2017 Jan 3;49(1):
pubmed: 28049168
Front Med (Lausanne). 2021 Sep 01;8:588013
pubmed: 34540855
BMC Geriatr. 2020 Oct 7;20(1):393
pubmed: 33028215
Am J Med. 2015 Nov;128(11):1225-1236.e1
pubmed: 26159634
Eur Geriatr Med. 2020 Dec;11(6):1009-1015
pubmed: 32770462
J Gerontol A Biol Sci Med Sci. 2020 Sep 25;75(10):1928-1934
pubmed: 32274501
Chest. 2021 Oct;160(4):1292-1303
pubmed: 34089741
Age Ageing. 2021 Sep 11;50(5):1719-1727
pubmed: 33744918
PLoS One. 2016 Jun 14;11(6):e0157377
pubmed: 27300577
Eur Respir J. 2021 Apr 29;57(4):
pubmed: 33419891
BMJ Open Qual. 2020 Jan;9(1):
pubmed: 31986119
J Acquir Immune Defic Syndr. 2021 Dec 15;88(5):518-527
pubmed: 34757975
Clin Transplant. 2021 Apr;35(4):e14236
pubmed: 33527520
Eur Respir J. 2020 Jan 23;55(1):
pubmed: 31537699
Respirology. 2017 May;22(4):728-734
pubmed: 27860036
Eur Respir J. 2021 Apr 29;57(4):
pubmed: 33303539